Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.98 EUR | +1.02% | +4.74% | -11.95% |
Sep. 29 | Shedir Pharma increases profit and revenues in the first half by double digits | AN |
Sep. 29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2023 * | 58.3M 62.94M | Sales 2024 * | 63M 68.01M | Capitalization | 45.26M 48.86M |
---|---|---|---|---|---|
Net income 2023 * | 6M 6.48M | Net income 2024 * | 6M 6.48M | EV / Sales 2023 * | 0.67 x |
Net cash position 2023 * | 6.3M 6.8M | Net cash position 2024 * | 14.3M 15.44M | EV / Sales 2024 * | 0.49 x |
P/E ratio 2023 * |
7.51
x | P/E ratio 2024 * |
6.75
x | Employees | 65 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 12.01% |
1 day | +1.02% | ||
1 week | +4.74% | ||
Current month | -0.50% | ||
1 month | -0.50% | ||
3 months | -9.95% | ||
6 months | -12.72% | ||
Current year | -11.95% |
Managers | Title | Age | Since |
---|---|---|---|
Antonio Scala
CEO | Chief Executive Officer | 39 | 13-12-31 |
Giuseppe Somma
IRC | Investor Relations Contact | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Mazzarese
BRD | Director/Board Member | 45 | 18-12-31 |
Lucio Fusaro
BRD | Director/Board Member | 68 | 21-12-31 |
Umberto di Maio
FOU | Founder | 51 | 14-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3.98 | +1.02% | 2,750 |
24-03-27 | 3.94 | +3.14% | 12,750 |
24-03-26 | 3.82 | +0.53% | 1,750 |
24-03-25 | 3.8 | 0.00% | 2,250 |
24-03-22 | 3.8 | 0.00% | 0 |
Real-time Borsa Italiana, March 28, 2024 at 12:44 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.95% | 48.89M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+2.95% | 212B | |
+0.74% | 209B | |
-6.05% | 205B | |
-3.61% | 157B |